ClinicalTrials.Veeva

Menu

Analysis of Prevalence and Risk Factors Associated With Gastroesophageal Reflux Disease and Esophagitis After Peroral Endoscopic Myotomy

M

Maria Sklodowska-Curie National Research Institute of Oncology

Status

Enrolling

Conditions

Achalasia
GERD

Treatments

Other: Patients who underwent POEM

Study type

Observational

Funder types

Other

Identifiers

NCT05080634
22042020

Details and patient eligibility

About

Achalasia is an uncommon disorder that results from the degeneration of ganglion cells of the myenteric plexus in the lower esophageal wall. Peroral endoscopic myotomy (POEM) is a minimally invasive procedure capable of overcoming limitations of achalasia treatments. This study aimed to: 1) identify the prevalence of reflux esophagitis and asymptomatic GERD in patients who underwent POEM, and 2) evaluate patient and intraprocedural variables associated with post-POEM GERD.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Males and females who are 18 years of age and older and are willing to sign an Informed Consent Form (ICF)
  2. Achalasia patients who underwent POEM

Exclusion criteria

  1. Lack of written consent for participation in the study
  2. Conditions which are contraindication to Esophagogastroscopy and High-resolution Esophageal Manometry

Trial contacts and locations

1

Loading...

Central trial contact

Aleksandra Budnicka-Borkowicz, MD; Anna Chaber-Ciopińska, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems